Saturday, June 16, 2018

Further Advances in Stem Cell Research for Spinal Cord Injuries

The SciStar study is an ongoing clinical trial evaluating the safety of three sequential escalating doses of AST-OPC1 for recent cervical spinal cord injury victims. AST-OPC1 consists of neural cells known as oligodendrocyte progenitor cells, and these cells are produced from human embryonic stem cells. The second phase of the Dose Escalation Study of AST-OPC1 … Continue reading "Further Advances in Stem Cell Research for Spinal Cord Injuries"

The post Further Advances in Stem Cell Research for Spinal Cord Injuries appeared first on Personal Injury Lawyer Los Angeles - Law Office of Tawni Takagi.

No comments:

Post a Comment